ABSTRACT Fermentable carbohydrates may enhance the ability of the gastrointestinal tract to defend against pathogenic infection. We hypothesized that a mannoserich, galactoglucomannan oligosaccharide-arabinoxylan (GGMO-AX) complex would positively impact immune status and prevent weight loss resulting from acute coccidiosis (Eimeria acervulina) infection of chicks. Using a completely randomized design, 1-d-old commercial broiler chicks (n = 160; 4 replications/treatment; 5 chicks/replication) were assigned to one of 4 cornsoybean meal-based diets containing supplemental GG-MO-AX (0, 1, 2, or 4%) that replaced dietary cellulose. On d 9 posthatch, an equal number of chicks on each diet were inoculated with either distilled water (sham control) or E. acervulina (1 × 10 6 oocysts). All birds were euthanized on d 7 postinoculation (PI) for collection of cecal contents and duodenal tissue. Overall, BW gain of chicks was not affected by diet PI, whereas infection decreased (P < 0.01) weight gain on d 0 to 7 PI. Feed intake was not affected by dietary treatment, but infection decreased (P < 0.01) feed intake on d 0 to 7 PI. Overall, infection, but not diet, decreased (P < 0.01) G:F on d 0 to 7 PI. Cecal propionate concentrations were independently affected by infection and diet, while butyrate concentrations were affected only by infection (P = 0.02). Cecal Bifidobacterium spp. populations were affected (P < 0.01) by diet, with the 2% GGMO-AX resulting in the highest cfu/g of cecal contents (on a DM basis). Messenger RNA expression of all duodenal cytokines evaluated was affected by infection status (P ≤ 0.02) but not by dietary treatment alone. Supplementing 4% GGMO-AX consistently resulted in the greatest fold change in proinflammatory cytokine expression, while inhibiting antiinflammatory cytokine expression, which indicates a more robust innate immune response. Despite decreasing performance, 4% dietary GGMO-AX improved select fermentation indices and the innate intestinal immune response to an acute E. acervulina infection.
INTRODUCTION
Avian coccidiosis is caused by several species of Eimeria, an infectious protozoan that penetrates and damages the epithelial cells of intestinal tissue, and is estimated to cost US $3 billion in annual production losses worldwide (Williams, 1999; Dalloul and Lillehoj, 2006) . In particular, Eimeria acervulina invades the duodenal intestinal epithelium, resulting in intestinal inflammation and, potentially, intestinal hemorrhaging (Lillehoj and Trout, 1996) . The intestinal damage results in decreased animal growth and feed efficiency, as well as diarrhea and mortality, all of which have significant implications for the commercial poultry industry.
The avian intestinal tract possesses numerous defenses to help protect against and overcome infection, with cell-mediated, or innate, immunity serving as an important first line of defense for a coccidiosis infection. Certain cytokines, including interferon-γ (IFN-γ) and interleukin (IL-1β), serve as important mediators during a coccidiosis challenge, as these proteins are associated with a disruption in Eimeria reproduction and improved BW gain during an E. acervulina infection (Lowenthal et al., 1997; Lillehoj and Choi, 1998) . Cytokine production of an appropriate magnitude and duration is crucial to quickly restore the animal to a healthy state, while minimizing expenditure of costly nutrient and energy resources to support immune defenses.
Research has shown a positive correlation between the effect of fermentable carbohydrates and improved intestinal health. Fiber fermentation in the distal segment of the intestinal tract may benefit the immune status of the entire gut by several potential mecha-nisms, including increased mucin thickness, modulation of epithelial inflammation by short-chain fatty acids (SCFA), increased resistance to microbial colonization, and enhanced immune activity (Cavaglieri et al., 2003; Tedelind et al., 2007; Hedemann et al., 2009; Ito et al., 2009) . Through these mechanisms, the detrimental effects of E. acervulina infection may be limited or eliminated in the intestine.
Mannanoligosaccharides (MOS), a fermentable oligosaccharide mainly derived from yeast cell wall (YCW), has been extensively evaluated for its ability to improve weight gain and feed conversion and decrease mortality in chickens (Hooge, 2004) . In addition, YCW has been shown to modulate the immune system of chicks (Gao et al., 2008; Janardhana et al., 2009) . Perhaps more than any other compound, MOS have been repeatedly shown to elicit beneficial effects in Eimeria-infected chicks (Elmusharaf et al., 2006 (Elmusharaf et al., , 2007 Gao et al., 2009) .
A novel source of MOS can be found in a galactoglucomannan oligosaccharide-arabinoxylan (GGMO-AX) complex carbohydrate (Price et al., 2011) . The GGMO-AX complex, a coproduct of the fiberboard manufacturing industry, is well fermented when evaluated both in vitro and in vivo (Faber et al., 2011a,b) .
It has yet to be determined, however, if the GGMO-AX complex can positively modulate the intestinal immune system. Thus, a coccidiosis-induced immune response may be an appropriate model to test the effects of this novel GGMO-AX complex.
The objective of this experiment was to determine the effects of a supplemental GGMO-AX complex in diets with emphasis on growth performance, fermentative and microbial effects, and immune indices in chicks challenged with an acute coccidial (Eimeria acervulina) infection.
MATERIALS AND METHODS
All animal care procedures were approved by the University of Illinois Institutional Animal Care and Use Committee and Institutional Biosafety Committee before initiation of the experiment.
Galactoglucomannan Oligosaccharide Substrate
Production of the GGMO-AX substrate involves use of wood chips, water, and pressure, but does not use strong acids or bases, unlike other fiberboard production processes. This results in an ingredient better tailored for consumption by animals. During hydrolysis, hemicelluloses are depolymerized through hydronium ions from water and other compounds, such as uronic, acetic, and phenolic acids (Garrote et al., 1999) . The release of pressure on material in the wood-chip digester results in destruction primarily of cellulose, hemicelluloses, and lignin, which, in turn, releases soluble sugars into the surrounding water, along with polyphenolic compounds from lignin. The resulting water solution contains increased concentrations of sugars (3-4% wt/ wt), a concentration unsafe for disposal into wastewater streams. Thus, the sugar solution is removed from the wood chips and further condensed into a viscous liquid (i.e., syrup) with a final sugar concentration of 30 to 54% (Michalka, 2007) ; in this final product, sugars are mostly found in the oligosaccharide form and not free sugars.
To obtain a dry product, the GGMO-AX syrup was spray-dried (Valentine Chemicals, Lockport, LA), with an inlet temperature approximately 155°C and exit temperature of 102°C; the starting substrate was adjusted to 53% solids before drying. Spray-drying allowed the substrate to be mixed in a mash diet matrix that was appropriate for young chicks.
Chicks and Husbandry
One hundred and 60, 1-d-old male Ross × Ross broiler chicks were used in this experiment. Chicks were housed in thermostatically controlled starter batteries with raised wire floors in an environmentally controlled room with continuous lighting. At hatch, chicks were weighed, wing-banded, and assigned to treatment groups, so that the initial weight was similar among treatment groups. Four replicates of 5 chicks were assigned to each treatment in the experiment. Chicks were randomly assigned to both an infection treatment (sham-inoculated vs. E. acervulina-inoculated) and a dietary treatment that differed only in GGMO-AX concentration (0, 1, 2, or 4% of as-is diet); GGMO-AX supplementation occurred at the expense of cellulose (Solka-Floc; International Fiber Corporation, North Tonawanda, NY). All diets were formulated to meet or exceed NRC (1994) recommendations (Table 1) , and feed and fresh water were offered ad libitum. Chicks and feeders were weighed on d 1, 3, and 6 posthatch and each day between d 9 to 16 posthatch to determine weight gain and feed intake before and during coccidial infection.
Inoculation
Sporulated E. acervulina oocysts (Parasite Biology and Epidemiology Lab, USDA, Beltsville, MD) were diluted with distilled water immediately before inoculation. Chicks were administered a 0.5-mL oral dose of either 1 × 10 6 sporulated E. acervulina oocysts or distilled water on d 9 posthatch using 1-mL syringes without needles (Jacobs, 2011) . Infection status was assessed by decreased weight gain and feed intake.
Sample Collection
On d 16 posthatch (d 7 postinoculation, PI) chicks were euthanized by CO 2 inhalation. Chicks were immediately dissected and ceca were removed and contents pooled per replicate pen of chicks. An aliquot of cecal digesta was gently squeezed out and immediately trans-ferred to a sterile cryogenic vial (Nalgene, Rochester, NY) and snap-frozen in liquid nitrogen. Additional aliquots were taken for measurement of pH, DM, SCFA, and branched-chain fatty acids (BCFA). Duodenal and spleen tissue were sampled from 2 randomly chosen chicks per replicate. Duodenal and splenic tissues were rinsed with PBS (pH 7.2), minced with a scalpel, placed in RNAlater solution, and stored at −80°C pending analysis. Oocyst shedding was not assessed in this study.
Chemical Analyses
Fresh cecal samples were analyzed for DM using AOAC (2006) methods. Cecal SCFA and BCFA concentrations were determined by gas chromatography according to Erwin et al. (1961) using a gas chromatograph (Hewlett-Packard 5890A series II, Palo Alto, CA) and a glass column (180 cm × 4-mm i.d.) packed with 10% SP-1200/1% H 3 PO 4 on 80/100+ mesh Chromosorb WAW (Supelco Inc., Bellefonte, PA); nitrogen was used as the carrier gas with a flow rate of 75 mL/ min. Oven, detector, and injector temperatures were 125, 175, and 180°C, respectively.
Microbial Analyses
Cecal microbial populations were analyzed using methods described by Middelbos et al. (2007) with minor adaptations. Briefly, cecal DNA was extracted from freshly collected samples that had been stored at -80°C, based on the repeated bead beater method described by Yu and Morrison (2004) , followed by use of a DNA extraction kit (QIAamp DNA Stool Mini Kit, Qiagen, Valencia, CA) according to the manufacturer's instructions. A TissueLyser apparatus (Qiagen) with a 5-mm steel bead (30 s at 15 Hz) was used in lieu of the repeated bead beater. Extracted DNA was quantified using a spectrophotometer (NanoDrop ND-1000, Nano-Drop Technologies, Wilmington, DE). Quantitative PCR was performed using specific primers for Bifidobacterium spp. (Matsuki et al., 2002) , Lactobacillus spp. (Collier et al., 2003) , Escherichia coli (Malinen et al., 2003) , and Clostridium perfringens (Wang et al., 1994) . Amplification was performed according to Deplancke et al. (2002) . Briefly, a 10-μL final volume contained 5 μL of 2X SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA), 15 pmol of the forward and reverse primers for the bacterium of interest, and 10 ng of extracted cecal DNA. Standard curves were obtained by harvesting pure cultures of the bacterium of interest in the log growth phase in triplicate, followed by serial dilution. Bacterial DNA was extracted from each dilution, using a DNA extraction kit as stated above, and amplified with the fecal DNA to create triplicate standard curves (ABI PRISM 7900HT Sequence Detection System, Applied Biosystems). Colony-forming units in each dilution were determined by plating on specific agars; lactobacilli MRS (Difco, BD, Franklin Lakes, NJ) for lactobacilli, reinforced clostridial medium (Bifidobacteria), and Luria Bertani medium (E. coli). The calculated log cfu per milliliter of each serial 
Inflammatory Cytokine Analyses
Total RNA was extracted from duodenal and spleen tissues using the Qiazol Lysis Reagent protocol (Qiagen) and the TissueLyser apparatus described above. Extracted RNA was quantified using a spectrophotometer (NanoDrop ND-1000, Nano-Drop Technologies). Ribonucleic acid samples were subjected to a 7X gDNA Wipeout Buffer and then converted to complementary DNA (cDNA) using a QuantiTec Reverse Transcription kit (Qiagen). Wipeout of gDNA and reverse transcription was performed in a thermocycler (model PTC-200, Biorad, Hercules, CA) with the program set for 2 min at 42°C, 2 min at 4°C, 15 min at 42°C, 3 min at 95°C, and then cooled to 4°C. The cDNA synthesized was stored at −20°C.
Quantitative real time PCR was performed using the Applied Biosystems TaqMan gene expression assay as described previously (Dilger and Johnson, 2010) . The cDNA was amplified by PCR where a target cDNA (IFN-γ, Y07922; IL-1β, Y15006; IL-6, AJ309540; IL-12β, NM_213571; and IL-15, AF139097) and reference cDNA [glyceraldehyde 3-phosphate dehydrogenase (GAPDH), K01458; Hong et al., 2006] were amplified using Taqman (Invitrogen), an oligonucleotide probe with a 5′ fluorescent reporter dye (6-FAM) and a 3′ nonfluorescent quencher dye (NFQ). Fluorescence was determined on an ABI PRISM 7900HT-sequence detection system (Applied Biosystems). To normalize gene expression, a parallel amplification of endogenous GAPDH was performed for each gene. Reactions with no reverse transcription and no template were included as negative controls. Data were analyzed using the comparative threshold cycle (C t ) method (Livak and Schmittgen, 2001) , and results are expressed as foldchange relative to the control treatment.
Statistical Analyses
Data were analyzed by ANOVA with procedures appropriate for a completely randomized design. Data for continuous variables were analyzed by the MIXED procedure (SAS Institute, Cary, NC). The statistical model included the fixed main effects of infection and dietary treatment. Additionally, interactive effects were evaluated using polynomial contrasts (linear and quadratic) designed for the nonequally spaced levels of supplemental GGMO-AX versus infection status. Least squares means were separated using least squares differences with a Tukey adjustment. Outlier data were removed from analysis after analyzing data using the UNIVARIATE procedure to produce a normal probability plot based on residual data and visual inspection of the raw data. Outlier data were defined as data points 3 or more SD from the mean. Differences among treatment level least squares means with a probability of P < 0.05 were accepted as statistically significant, whereas mean differences with P-values ranging from 0.06 to 0.10 were accepted as trends.
RESULTS
Overall, BW gain of chicks was not affected by diet PI, whereas infection decreased (P < 0.01) weight gain on d 0 to 7 PI (Table 2 ). An interaction of infection by quadratic response to diet (Quad Dt; P < 0.01) affected weight gain on d 0 to 3 PI. On d 0 to 7 PI, an infection by Quad Dt (P = 0.06) was noted. Overall, feed intake was not affected by dietary treatment. Numerically, uninfected chicks fed 4% GGMO-AX diet exhibited the lowest feed intake, whereas infected chicks fed the 4% GGMO-AX diet exhibited the greatest feed intake during all time periods. Infection decreased (P < 0.01) feed intake on d 0 to 7 PI. Overall, infection, but not diet, decreased (P < 0.01) G:F on d 0 to 7 PI. An interaction of infection by linear response to diet (Lin Dt; P < 0.01) was observed for G:F during d 0 to 7 PI.
Cecal acetate and total SCFA concentrations were not affected by infection or diet. Infection and diet affected (P < 0.01) propionate concentrations independently. As the dietary concentration of GGMO-AX increased, propionate concentrations decreased. Cecal butyrate concentrations were not affected by diet (P = 0.26) but were affected by infection (P = 0.02), with infected chicks having greater concentrations of butyrate than uninfected chicks. Cecal BCFA (isobutyrate, isovalerate, valerate, and total BCFA) concentrations were not affected by infection or dietary treatment.
Cecal pH was greater (P < 0.01) in infected chicks than uninfected chicks (Figure 1 ). In addition, diet affected (P < 0.01) cecal pH, regardless of infection status. As the dietary concentration of GGMO-AX increased, cecal pH linearly decreased (P < 0.01), but no interaction effects were noted.
Cecal Bifidobacterium spp. populations were affected (P < 0.01) by diet, with the 2% GGMO-AX resulting in the highest cfu/g of cecal contents (on a DM basis). Cecal E. coli populations were increased (P = 0.01) due to infection. An infection by Ln Dt trend (P = 0.08) was noted, as dietary GGMO-AX concentration increased, E. coli populations increased in uninfected chicks while populations decreased in infected birds. Cecal Lactobacillus spp. populations were greater (P < 0.01) in infected chicks, regardless of diet.
Messenger RNA expression of all duodenal cytokines evaluated was affected by infection status (P ≤ 0.02), but not by dietary treatment alone. An infection by Lin Dt and Quad Dt tended (P = 0.10 and 0.06, respectively) to affect IL-15 expression. An infection by Quad Dt also tended (P = 0.06) to affect IL-12β expression. Neither infection nor diet affected cytokine mRNA expression in the spleen (data not shown).
DISCUSSION
The intestinal and systemic health benefits of dietary fiber, particularly fermentable carbohydrates, in human and animal nutrition suggest fiber to be an important dietary ingredient. In addition, some oligosaccharides, particularly MOS, may directly prevent pathogenic bacteria from binding to epithelial cells in the small intestine and prevent colonization and proliferation in the intestinal tract (Grieshop et al., 2004; Gouveia et al., 2006; Baurhoo et al., 2009) . We hypothesized that ingestion of a novel fermentable carbohydrate, GGMO-AX, could improve the immune response of growing chickens to an acute E. acervulina infection through fermentative changes, and possibly through an MOSdependent mechanism, in the distal gastrointestinal tract. Results of our studies suggest that while the GG-MO-AX complex can be fermented by the young chick, direct alteration of the immune profile was insufficient to provide significant protection from the acute coccidial infection that was induced.
Overall, dietary GGMO-AX supplementation did not alter chick BW gain either pre-or postinoculation with E. acervulina. In a meta-analysis of 44 broiler trials evaluating MOS mainly derived from YCW, 79.5% of the trials reported improved weight gain due to provision of this carbohydrate alone (Hooge, 2004) . Differences in substrate characteristics, including levels of β-glucans and crude protein, may help explain improved growth performance in chicks fed MOS directly, and it is possible that concentrations of MOS provided from GGMO-AX in our studies did not reach a minimum threshold to elicit this type of response.
Following inoculation with E. acervulina, clear differences in weight gain were expected as attributable to several factors. First, the observed decrease in feed intake was likely due to an increase in systemic cytokine expression. Select cytokines, particularly IL-1β and TNF-α, are known to decrease both feed intake and feed efficiency in animal models (Klasing et al., 1987; Beutler and Cerami, 1989; Johnson, 1997) . However, in the current study, the greatest numerical differences in cytokine mRNA expression due to E. acervulina inoculation were observed in chicks receiving 4% dietary GGMO-AX complex, suggesting that dietary fermentation characteristics may directly affect an active immune response. Infected chicks fed more dietary GGMO-AX linearly decreased in feed efficiency, which suggests a maximum threshold for fermentable carbohydrate ingestion by the chick. Second, chicks experience a decrease in digestibility of ME, glucose, fat, and amino acids, as indicated by both in vitro and in vivo experiments (Ruff and Wilkins, 1980; Adams et al., 1996; Persia et al., 2006; Jacobs, 2011) . PrestonMafham and Sykes (1970) showed that the decrease in feed intake due to infection accounts for approximately 30 to 70% of the decrease in weight gain, as determined in uninfected chicks that were pair-fed with infected Table 2 . Body weight gain (g), feed intake (g/chick), and gain:feed (g/kg) of broiler chicks fed a diet (Dt) supplemented with a galactoglucomannan oligosaccharide-arabinoxylan (GGMO-AX) complex and infected (Inf.) with or without Eimeria acervulina on select days postinoculation (PI) chicks. Moreover, decreases in nutrient digestibility are known to occur concomitantly with changes in intestinal enzyme activity, which are associated with Eimeria-induced damage of duodenal tissue (Adams et al., 1996) . Lastly, dietary energy and endogenous resources (e.g., amino acids) are required to mount an active immune response, which decreases available substrates for BW gain and maintenance in the rapidly growing chick (Lochmiller and Deerenburg, 2000; Humphrey and Klasing, 2004) .
Fermentation of substrates by commensal bacteria results in the production of SCFA, which lowers the pH of the fermentative segment of the gastrointestinal tract (i.e., the ceca in avian species). As concentration of fermentable substrate increases, colonic pH decreases (Roberfroid, 2007) . Despite a decrease in cecal pH with increasing GGMO-AX concentrations, total SCFA concentrations were unaffected. In contrast, a linear increase in total fecal SCFA was observed in dogs receiving diets containing up to 8% GGMO-AX (Faber et al., 2011b) , so lack of a similar response in chickens was perplexing. But cecal SCFA concentration is only part of the story, as total cecal volume is not an inherent property of this measurement. Fermentable substrates are known to increase cecal volume (Berggren et al., 1993; Campbell et al., 1997) , which would effectively serve to dilute SCFA concentrations. Thus, it is highly probable that differences in total SCFA production would have been observed if our data were expressed on total cecal volume basis compared with concentration alone (Berggren et al., 1993; Campbell et al., 1997; Knapp, 2011) .
Eimeria acervulina-infected chicks had a greater cecal pH compared with uninfected chicks, which is similar to results of Ruff et al. (1974) on d 7 PI. This may be the result of a change in the microbial populations as noted in the current study, because total SCFA concentrations were similar among treatments. Significant increases in E. coli and Lactobacillus spp. were noted in infected chicks, likely resulting in increased propionate and butyrate concentrations. An increase in the quantity and type of available fermentable substrate would modulate the microbiome, resulting in a shift in the profile of fermentative end products being produced. Therefore, populations of E. coli may have been enhanced in infected chicks due to higher cecal pH. To our knowledge, no other study has evaluated cecal SCFA concentrations in chicks inoculated with E. acervulina.
Messenger RNA cytokine expression is a common method to evaluate the immune response elicited by various tissues to an infectious organism. In our studies, infected chicks receiving 4% supplemental GGMO-AX had increased mRNA expression of pro-inflammatory cytokines (IFN-γ, IL-1β, IL-6, IL-12 β) and lower expression of anti-inflammatory cytokine IL-15, compared with infected chicks receiving 0% dietary GG-MO-AX. Previous research suggested chicks that were genetically enhanced to elicit a strong innate immune response had reduced weight loss and fecal oocyst shedding with greater IL-1β, IL-6, and IL-8 expression after an E. maxima infection (Kim et al., 2008) . In addition, the simultaneous administration of recombinant IFN-γ and E. acervulina to chicks was associated with a decrease in oocyst excretion and improved BW gain (Lowenthal et al., 1997; Lillehoj and Choi, 1998) . However, in our study, increased cytokine expression on d 7 PI was associated with lower weight gain, which highlights the complexity associated with cytokine signaling. Nonetheless, the more robust cytokine response observed may aid the chick in overcoming infection in less time, which would translate into direct benefits for production efficiency. Additionally, we speculate that a greater innate immune response may enhance the acquired immunity to subsequent infections, and thereby potentially ameliorate the negative effects of a secondary infection (Medzhitov and Janeway, 1997; Parish and O'Neill, 1997; Iwasaki and Medzhitov, 2010) .
Although the GGMO-AX substrate was fermented in the ceca, modulation of cytokine expression clearly occurred at proximal sites in the gastrointestinal tract (i.e., the duodenum). This suggests that the GGMO-AX substrate provided at 4% of the diet elicited a systemic alteration of the immune response to an intestinal infection. Although not evaluated in our study, the immune response in the cecal tonsils may have been enhanced during the Eimeria infection. Cecal tonsils are the major lymphoid tissue of the ceca, and represent the largest collection of gut-associated lymphoid tissue in the chicken (Yun et al., 2000) . Cytokine expression in the spleen was measured as an indicator of systemic immune activity, but no changes were noted in this tissue, suggesting that only the intestinal lymphatic system was responding to the infection and not the systemic lymphatic system. Short-chain fatty acids in vitro and in vivo have been shown to modulate cytokine expression of lymphocytes and intestinal tissue (Milo et al., 2002; Cavaglieri et al., 2003; Pié et al., 2007) . Infected chicks receiving the 1% GGMO-AX treatment had the lowest cecal acetate, butyrate, and total SCFA concentrations, yet duodenal mRNA expression of IL-6 and IL-12β were elevated compared with chicks receiving other dietary treatments.
The benefits of fermentable fiber to digestive and host health are well accepted. Limited research has been conducted on the ability of fermentable fibers to positively improve intestinal health indices during an E. acervulina challenge. In this study, chicks infected with E. acervulina had decreased growth performance and increased fermentation and immune responses compared with uninfected chicks. Dietary supplementation with GGMO-AX decreased feed efficiency of infected chicks, but improved select cecal health indices (e.g., decreased cecal pH and positive modulation of select microbiota). Supplementing 4% GGMO-AX, a relatively high dietary concentration for chicks, consistently resulted in the greatest fold change in pro-inflammatory cytokine expression, while inhibiting anti-inflammatory cytokine expression, which indicates a more robust innate immune response. Despite decreasing growth performance, dietary supplementation with GGMO-AX improved the innate intestinal immune response to an acute E. acervulina infection.
